U.S. Intravenous Solutions Market To Generate a Significant Revenue of US$ 4,385.7 Million By 2027 | CAGR: 6.4%: Coherent Market Insights
Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
U.S. Intravenous Solutions Market, by Solution Type (Saline (Normal Saline (0.9% NaCl) and Hypertonic Saline), Dextran, Lactated Ringer’s, Amino Acid, Vitamins & Minerals, Heparin, and Trace Elements, and Mixed Solutions), by Bag Type (Large Volume Bags (greater than 250ml) and Small Volume Bags (less than 250ml)), By Application (Basic IV Solution, Nutritional IV Solution, Blood IV Solution, Drug IV Solution, and Irrigation IV Solution), By End User (Hospitals, Clinics, Ambulatory Surgery Centers, and Home Care Settings), is estimated to be valued at US$ 2,665.5 million in 2019 and is estimated to exhibit a CAGR of 6.4% over the forecast period (2019 – 2027), as highlighted in a new report published by Coherent Market Insights.
Get FREE Sample PDF Including COVID-19 Impact Analysis: https://www.coherentmarketinsights.com/insight/request-pdf/3400
IV solutions are important and are required by almost every hospitalized patient. Moreover, the increasing number of hospitals, coupled with hospitalization rates in the U.S. are expected to augment growth of the U.S. IV solutions market over the forecast period. For instance, according to the American Hospital Association 2019, the number of hospitals in the U.S. increased to 6,210 in 2019 from 5,534 in 2018 to cater to the increasing treatment requirement of the patient population.
Additionally, according to American Hospital Association 2019, the total admissions in hospitals was 36,510,207 in January 2019, which increased from 35,158,934, an increase by 3.4% from 2018
Furthermore, the U.S. intravenous solutions market is expected to witness significant growth over the forecast period, attributed to presence of key players in the country such as Baxter International Inc. and ICU Medical, Inc., among others.
Browse 12 Market Data Tables and 24 Figures spread through 131 Pages and in-depth TOC on “U.S. intravenous solutions market, by Solution (Saline (Normal Saline (0.9% NaCl) and Hypertonic Saline), Dextran, Lactated Ringer’s, Amino Acid, Vitamins & Minerals, Heparin and Trace Elements, and Mixed Solutions), by Bag Type (Large Volume Bags (greater than 250ml) and Small Volume Bags (less than 250ml)), by Application (Basic IV Solution, Nutritional IV Solution, Blood IV Solution, Drug IV Solution, and Irrigation IV Solution), by End User (Hospitals, Clinics, Ambulatory Surgery Centers, and Home Care Settings) – U.S. Forecast to 2027”
To know the latest trends and insights related to U.S. intravenous solutions market press release, click the link below: https://www.coherentmarketinsights.com/press-release/us-intravenous-solution-market-2763
Key Takeaways of the U.S. Intravenous Solutions Market:
- S. intravenous solutions market is expected to exhibit a CAGR of 6.4%over the forecast period (2019-2027), attributed to increasing number of hospitals, coupled with increasing hospitalization rates.
- On the basis of solution type, saline solution segment is expected to account for major market share, in terms of revenue in 2027. A saline solution is a mixture of sodium chloride in water, and used as an intravenous solution for treating dehydration, gastroenteritis and diabetic ketoacidosis.
- Key players operating in U.S. intravenous solutions market include Baxter International Inc., ICU Medical, Inc., B. Braun Melsungen Ag, and Grifols, S.A.
Apply Promo Code “STAYHOME” And Get an Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/3400
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
- CDN Newswire